Body mass index (β-F/M = 113.3/55.3), serum ALT (β-F/M = 21.6/53.8), and platelet count (β-F/M = 13.8/11.8) were positively associated with NAFLD in both genders. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.